Trial intelligence / Profile preview

RUTI therapeutic vaccination in multidrug-resistant tuberculosis after intensive-phase treatment

NL-OMON43117Phase 2Withdrawn

Sponsor
Archivel Farma
Start
Oct 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2 trial of RUTI vaccine, sponsored by Archivel Farma. Planned start Oct 2016; status: withdrawn.

02

Drugs

RUTI vaccine

Beyond the preview

Go deeper on NL-OMON43117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON43117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call